Concepedia

Kamal Abeywickrama

KA

Statistics

Publications

17

Citations

3.5K

H-Index

13

Active since

1985

Affiliations

Novartis (Switzerland)(Current)

Cleveland Clinic

Sanden (Japan)

Sorbonne Université

University of California, Los Angeles

Kamal Abeywickrama is an author at Novartis (Switzerland) specializing in medicine, transplant rejection, and heart transplantation.

Publications per year

1985–2007

17

Publications

17

Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients

Howard J. Eisen, E. Murat Tuzcu, Richard Dorent et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

, , +4

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

Björn Nashan, Richard H. Moore, P L Amlot et al. · The Lancet · 1997 · 762 citations

, , +15

Multicenter Intravascular Ultrasound Validation Study Among Heart Transplant Recipients

Jon Kobashigawa, Jonathan M. Tobis, Randall C. Starling et al. · Journal of the American College of Cardiology · 2005 · 416 citations

, , +12

A computer program package for relative survival analysis

Timo Hakulinen, Kamal Abeywickrama · Computer Programs in Biomedicine · 1985 · 349 citations

, , +11

Efficacy and safety of oral cyclosporin A (CyA; SandimmunR) for long-term treatment of chronic severe plaque psoriasis

C. LABURTE, Rachel Grossman, J Abi-Rached et al. · British Journal of Dermatology · 1994 · 114 citations

, , +13

1–5 of 17